Lipids & metabolic liver disease

The association of C-reactive protein–triglyceride–glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

CTI and its cumulative exposure level are closely associated with both the prevalence and incidence risk of CMM, and these findings were further supported by validation in the independent longitudinal ELSA cohort. As a simple composite index derived from routinely measured indicators, CTI may help identify individuals at high risk of CMM and provide a reference for early risk stratification and intervention in middle-aged and older populations.

Study context

Population
Middle-aged and older adults free of cardiometabolic multimorbidity (CMM) at baseline, China Health and Retirement Longitudinal Study (CHARLS) 2011–2020CHARLS cohort
Participants
10,863 participants
Exposure
Higher vs lower C-reactive protein–triglyceride–glucose index
Outcome
Incident cardiometabolic multimorbidity (CMM)
Follow-up
≈9 years
Methodological detailsexternal longitudinal validation (English Longitudinal Study of Ageing (ELSA)), cross-sectional replication (National Health and Nutrition Examination Survey (NHANES)), prespecified subgroup analyses
  • External longitudinal validation (ELSA)
  • Cross-sectional replication (NHANES)
  • Prespecified subgroup analyses

Main finding

As reported in the abstract

Incident CMM (CHARLS) · approximately 9 years
Primary model
Hazard ratio (95% CI)
Per 1-unit CTI increase
1.71(1.39–2.11)
Highest CTI quartilevs Lowest CTI quartile
1.33(0.94–1.88)
Incident CMM cases
1698 (15.6%)

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Incident CMM per 1-unit increase in cumulative CTI (2015 baseline subcohort)1.02 (1.00–1.05)
Incident CMM, external validation (ELSA, n = 3129; 406 cases, 13.0%)Per 1-unit CTI increase · primary model1.59 (0.99–2.55)
Incident CMM, external validation (ELSA, n = 3129; 406 cases, 13.0%)Highest CTI quartilevs Lowest CTI quartilePrimary model2.22 (1.06–4.62)P for trend = 0.027

CMM prevalence (cross-sectional, CHARLS and NHANES)

Significant positive association between CTI and CMM prevalence, with a dose-response relationship

4-year CMM prediction: AUC after adding CTI to traditional risk factors

AUC increased from 0.753 to 0.778

Original publication

The association of C-reactive protein–triglyceride–glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies. Cardiovasc Diabetol. Published 13 February 2026. doi:10.1186/s12933-026-03109-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.